The doses of 35 and 40mg/kg STZ were effective in simulating metabolic characteristics of DM2 in humans.It was confirmed by the presence of polydipsia, hyperglycemia, altered biochemicaltests, insulin resistance and damages to the liver, pancreas, and kidney. This evidence concerns the gene INS and Polydipsia.